Technology News and Research

RSS

Zynx Health's clinical support solution receives US patent

Zynx Health, the market leader in providing evidence-based and experience-based clinical decision support solutions, today announced that the United States Patent and Trademark Office (USPTO) has issued United States Patent 7,822,626 covering their extensive suite of tools that facilitate and enhance the capability within a healthcare institution to establish and maintain an evidence-based best practice approach to providing patient care.

2 Nov 2010

Rubicon's PicoPlex kits provide DNA methylation profiling using next-generation sequencing

Rubicon Genomics today reported data demonstrating that its PicoPlex kits currently marketed for the analysis of single cells for research and diagnostic applications also provide important advantages for genetic and epigenetic profiling using next-generation sequencing (NGS).

2 Nov 2010

X-BODY receives research grant for therapeutic project against metastatic tumor stem cells

X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.

2 Nov 2010

PharmaTrust signs agreement with Sagamok community to provide MedCentre

PharmaTrust has signed the first agreement of its kind to provide a MedCentre to a First Nation community in northern Ontario. In a signing ceremony on October 29th the Sagamok Anishnawbek First Nation community finalized an agreement with PharmaTrust for the deployment of a MedCentre, which will give the community the option of convenient 24/7 access to pharmacy services.

2 Nov 2010

National Jewish Health's chronic urticaria diagnostic assay receives US patent

National Jewish Health has received a US patent for a method of detecting autoimmune chronic urticaria, which will help assure many patients that dramatic changes in lifestyle are not needed to treat the condition.

2 Nov 2010

454 Life Sciences and DNA Electronics partner to develop high-throughput DNA sequencing system

454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, high-throughput DNA sequencing system. As part of the agreement, Roche has signed a non-exclusive license for relevant IP from DNA Electronics' proprietary semiconductor technology portfolio, which enables sensitive detection of nucleotide incorporation during sequencing.

1 Nov 2010

Today's OpEds: Health law and private insurance; Corporate wellness programs; Geriatric mental health

Once again, average health insurance rates are expected to rise by double digits next yearas they have every year since 2002. ... Given that Obama would veto a repeal, we hope the next Congress instead begins the hard work of re-crafting the new law with a goal of breaking the annual spikes in cost (The Denver Post, 11/1).

1 Nov 2010

Calypso Medical to showcase FDA cleared Dynamic Edge Gating Technology at 52nd ASTRO

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced it will showcase Dynamic Edge™ Gating Technology, recently cleared by the U.S. Food and Drug Administration, at the 52nd Annual Meeting of the American Society for Radiation Oncology (ASTRO), now underway at the San Diego Convention Center.

1 Nov 2010

BSD MTX-180 MicroThermX Microwave Ablation System receives CE Mark approval

BSD Medical Corporation, the company that pioneered heat therapy applications, today reported that the Company has received CE Mark approval for the commercial sale of The MicroThermX Microwave Ablation System (MTX-180) in Europe. CE marking approval allows BSD to market the MTX-180 in the 30 countries that comprise the European Union (EU) and the European Free Trade Association (EFTA).

1 Nov 2010

International Isotopes completes private placement

International Isotopes Inc. announces completion of a private placement on October 29, 2010 that will immediately provide the company with approximately $5.8 million in cash to continue its efforts on the licensing and design of its planned environmentally friendly, green technology uranium de-conversion and fluorine extraction processing facility.

1 Nov 2010

GlycosBio, Malaysian Bio-XCell enter agreement to build biochemical plant and biotechnology R&D facility

Glycos Biotechnologies, Inc. (GlycosBio), an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today exchanged definitive agreements with Malaysian Bio-XCell for the establishment of the Company's industrial biochemical plant and biotechnology R&D facility in Malaysia

1 Nov 2010

Kaplan EduNeering opens new office in Hong Kong

Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, announces today the opening of a Hong Kong office to serve clients based in Asia. The new location, which will house sales and support staff, is based in the Hong Kong offices of its parent company, Kaplan, Inc. In 2008, Kaplan EduNeering opened a European-based location in Reading, England.

1 Nov 2010

HealthAlliance of the Hudson Valley to implement REACH3's CRM solution

REACH3 - healthcare CRM's market leader, enabling robust provider and payer marketing initiatives through secure, cloud-based technology - announced today that HealthAlliance of the Hudson Valley has chosen to implement its CRM Custom solution to strengthen its consumer and patient marketing campaigns, as well as enhance the unified brand identity of its newly formed health system.

1 Nov 2010

Porex sells surgical division to Stryker

Porex Corporation, a portfolio company of Los Angeles-based investment firm Aurora Capital Group, today announced that it has sold its Porex Surgical division to Stryker Corporation.

From Stryker 1 Nov 2010

XOMA receives final $2.0 million from Kaketsuken under antibody technology collaboration

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, today announced receipt of the final $2.0 million payment from Kaketsuken under the $8.0 million collaboration announced in November 2009. The agreement involves multiple proprietary XOMA antibody research and development technologies, including a new XOMA phage display library, and a suite of integrated information and data management systems.

1 Nov 2010

Cato Research selects BioClinica's clinical trial management system

BioClinica®, Inc.,, a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica's clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.

From Clario 1 Nov 2010

PreViser releases new web-based tool for oral health

PreViser Corporation announced today the release of a Web based tool, myDentalScore, that allows individuals to calculate objective numeric scores for oral disease risk and severity.

1 Nov 2010

Medicago receives Health Canada clearance for Phase II clinical trial of H5N1 Avian Influenza vaccine

Medicago Inc. a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has received clearance from Health Canada to commence a Phase II human clinical trial with its H5N1 Avian Influenza vaccine ("H5N1 vaccine"). Enrolment of volunteers is now underway.

1 Nov 2010

FDA grants orphan drug designation to Discovery's KL4 surfactant for CF treatment

Discovery Laboratories, Inc. today announced that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to Discovery's KL4 surfactant for the treatment of cystic fibrosis (CF).

1 Nov 2010

McKesson to acquire US Oncology

McKesson Corporation, a leading healthcare services and information technology company, and US Oncology, a leading integrated oncology company, announced today that the two companies have signed a definitive agreement under which McKesson will purchase all outstanding shares of US Oncology for cash.

1 Nov 2010

Technology News and Research

Zynx Health's clinical support solution receives US patent

Rubicon's PicoPlex kits provide DNA methylation profiling using next-generation sequencing

X-BODY receives research grant for therapeutic project against metastatic tumor stem cells

PharmaTrust signs agreement with Sagamok community to provide MedCentre

National Jewish Health's chronic urticaria diagnostic assay receives US patent

454 Life Sciences and DNA Electronics partner to develop high-throughput DNA sequencing system

Today's OpEds: Health law and private insurance; Corporate wellness programs; Geriatric mental health

Calypso Medical to showcase FDA cleared Dynamic Edge Gating Technology at 52nd ASTRO

BSD MTX-180 MicroThermX Microwave Ablation System receives CE Mark approval

International Isotopes completes private placement

GlycosBio, Malaysian Bio-XCell enter agreement to build biochemical plant and biotechnology R&D facility

Kaplan EduNeering opens new office in Hong Kong

HealthAlliance of the Hudson Valley to implement REACH3's CRM solution

Porex sells surgical division to Stryker

XOMA receives final $2.0 million from Kaketsuken under antibody technology collaboration

Cato Research selects BioClinica's clinical trial management system

PreViser releases new web-based tool for oral health

Medicago receives Health Canada clearance for Phase II clinical trial of H5N1 Avian Influenza vaccine

FDA grants orphan drug designation to Discovery's KL4 surfactant for CF treatment

McKesson to acquire US Oncology

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News